Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marguerite Parisi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pediatric Radiology|February 6, 2010
Infected thyroglossal duct cystPuneet Bhargava, Marguerite Parisi
Pediatric Radiology|January 10, 2009
Gastric pneumatosis and portal venous gas: benign findings in hypertrophic pyloric stenosisPuneet Bhargava, Marguerite Parisi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2019
Update: Image Gently and Nuclear Medicine at 10 YearsS Ted Treves, Michael Gelfand, Marguerite Parisi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 18, 2020
SNMMI Procedure Standard/EANM Practice Guideline on Pediatric <sup>18</sup>F-FDG PET/CT for Oncology 1.0Reza Vali, Adam Alessio, Rene Balza, et al.
Pediatric Blood & Cancer|April 7, 2017
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupSteven G DuBois, Rajen Mody, Arlene Naranjo, et al.
Journal of Nuclear Medicine Technology|July 15, 2025
2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical ActivitiesS Ted Treves, Frederic H Fahey, Valentina Ferrer Valencia, et al.
Frontiers in Immunology|July 4, 2018
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931M Fevzi Ozkaynak, Andrew L Gilman, Wendy B London, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
Summary of the 2024 Update of the North American Guidelines for Pediatric Administered Radiopharmaceutical ActivitiesS Ted Treves, Frederic H Fahey, Valentina Ferrer Valencia, et al.
Frontiers in Immunology|July 27, 2018
Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931M Fevzi Ozkaynak, Andrew L Gilman, Wendy B London, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pediatric Radiology|February 6, 2010
Infected thyroglossal duct cystPuneet Bhargava, Marguerite Parisi
Pediatric Radiology|January 10, 2009
Gastric pneumatosis and portal venous gas: benign findings in hypertrophic pyloric stenosisPuneet Bhargava, Marguerite Parisi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2019
Update: Image Gently and Nuclear Medicine at 10 YearsS Ted Treves, Michael Gelfand, Marguerite Parisi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 18, 2020
SNMMI Procedure Standard/EANM Practice Guideline on Pediatric <sup>18</sup>F-FDG PET/CT for Oncology 1.0Reza Vali, Adam Alessio, Rene Balza, et al.
Pediatric Blood & Cancer|April 7, 2017
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupSteven G DuBois, Rajen Mody, Arlene Naranjo, et al.
Journal of Nuclear Medicine Technology|July 15, 2025
2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical ActivitiesS Ted Treves, Frederic H Fahey, Valentina Ferrer Valencia, et al.
Frontiers in Immunology|July 4, 2018
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931M Fevzi Ozkaynak, Andrew L Gilman, Wendy B London, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
Summary of the 2024 Update of the North American Guidelines for Pediatric Administered Radiopharmaceutical ActivitiesS Ted Treves, Frederic H Fahey, Valentina Ferrer Valencia, et al.
Frontiers in Immunology|July 27, 2018
Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931M Fevzi Ozkaynak, Andrew L Gilman, Wendy B London, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Pageof 1